Dose accuracy testing of the Humalog®/Humulin® insulin pen device

Diabetes Technology and Therapeutics

Volumn 3, Issue 4, 2001, Pages 623-629

  Roe, Michael J ^a   Ignaut, Debra ^a   Miyakawa, Tom ^a   Hultman, Cheryl ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN INSULIN; INSULIN LISPRO;

ACCURACY; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; HUMIDITY; INSULIN PEN DEVICE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MODEL; PATIENT SATISFACTION; PRIORITY JOURNAL; RELIABILITY; TEMPERATURE; TORQUE;

DIABETES MELLITUS; EQUIPMENT DESIGN; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 0035724945     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/15209150152811252     Document Type: Article

References (4)

1. Patients and health care professionals evaluate a new pre-filled insulin pen device
2. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents
3. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe